Despite intensive use of the term “mild cognitive impairment” (MCI) to describe an intermediate stage of cognitive decline between normal and pathological brain ageing, no formally agreed process of characterizing this condition exists, say Fiona Matthews (MRC Biostatistics Unit, Cambridge, UK) and colleagues.
